Open AccessCorrection: Serum matrix metalloproteinase 3 levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs in patients with rheumatoid arthritis
Author(s) -
Nao Tokai,
Shuzo Yoshida,
Takuya Kotani,
Ayaka Yoshikawa,
Yuko Kimura,
Youhei Fujiki,
Yoko Matsumura,
Tohru Takeuchi,
Shigeki Makino,
Shigeki Arawaka
Publication year - 2019
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0211750
Subject(s) - rheumatoid arthritis , medicine , matrix metalloproteinase , matrix metalloproteinase 3 , arthritis , bioinformatics , pharmacology , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom